NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced that it has partnered with the University of Utah in analyzing the entire genomic profiles of at least 1,000 individuals who have a history of rare and life-threatening diseases and conditions in their respective families.
The landmark project will focus on researching the genetic causes of 25 conditions, including, breast, colon, ovarian, and prostate cancers, amyotrophic lateral sclerosis (ALS), chronic lymphocytic leukemia, autism, preterm birth, epilepsy, and other hereditary conditions, according to a press release from NantHealth.
Genomic sequencing will be conducted with unique, comprehensive molecular tests offered by NantHealth. The genomic sequencing platform integrates whole genome (DNA) sequencing, and RNA sequencing, as the press release notes.
By carrying out this extensive testing, including analysis of germline and somatic samples, University of Utah and NantOmics researchers will be able to explore the underlying genetic causes of certain conditions and diseases at the cellular level, as told by the press release.